UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2024 » Volume 32, issue 4 (121) » CLINICAL PHENOMENOLOGY AND MANAGEMENT OF MENTAL DISORDERS IN INDIVIDUALS WHO HAVE EXPERIENCED COVID-19

CLINICAL PHENOMENOLOGY AND MANAGEMENT OF MENTAL DISORDERS IN INDIVIDUALS WHO HAVE EXPERIENCED COVID-19

Authors

Type of Article

  • Scientific Article

In the Section

  • diagnosis and treatment of mental and behavioral disorders.

Key words

Index UDK:
  • 616.89-085.851:616.98:578.834

Abstract

In the course of the work, the clinical phenomenology was studied and a comprehensive system of therapy for mental disorders in people who have suffered from COVID-19 was developed.

It was established that the clinical picture of mental disorders in the examined patients is represented by depressive (29.1 % of patients), anxiety (33.4 %), asthenic-neurotic (24.2 %) and cognitive (13.3 %) syndrome complexes, and their phenomenology was described.

Taking into account the data obtained during the comprehensive examination, a personalized system for correcting mental disorders in people who have suffered from COVID-19 was developed, which included the use of pharmacotherapy, psychotherapy and psychoeducation.

Psychopharmacotherapy included the differentiated use of SSRI antidepressants and SSRI non-benzodiazepine anxiolytics, a short course of benzodiazepine.

Analysis of the clinical results of using the developed program of personalized therapy of mental disorders of people who have suffered COVID-19 has proven its effectiveness. Against the background of using the developed program, positive dynamics of the mental state, rapid reduction of anxiety-depressive and asthenic symptoms, improvement of cognitive functions, formation of adaptive types of attitude to the disease and improvement of the quality of life of people who have suffered COVID-19 were noted.

Pages

  • 10-13

Year / Issue

Download PDF

References

  1. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021 Oct;53(10):737-754. DOI:  https://doi.org/10.1080/23744235.2021.1924397.
  2. Legido – Quigley H, Asgari N, Teo  YY, Leung GM, Oshitani  H, Fukuda K, et al. Are  high-performing health systems resilient against the COVID-19 epidemic? Lancet. 2020 Mar 14;395(10227):848-850. DOI:  https://doi.org/10.1016/S0140-6736(20)30551-1.
  3. Coronavirus: statistics by country [Coronavirus: statistics by country]. URI: https://index.minfin.com.ua/ua/reference/coronavirus/geography/. (In Ukrainian).
  4. Cheng WJ, Shih HM, Su KP, Hsueh PR. Risk factors for poor COVID-19 outcomes in  patients with psychiatric disorders. Brain Behav Immun. 2023 Nov;114:255-261. DOI:  https://doi.org/10.1016/j.bbi.2023.08.024.
  5. Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et  al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020 Jun;7(6):547-560. DOI: https://doi.org/10.1016/S2215-0366(20)30168-1.
  6. Sheridan Rains L, Johnson S, Barnett P, Steare T, Needle JJ, Carr S, … Simpson A; COVID-19 Mental Health Policy Research Unit Group. Early impacts of the COVID-19 pandemic on mental health care and on  people with mental health conditions: framework synthesis of international experiences and responses. Soc Psychiatry Psychiatr Epidemiol. 2021 Jan;56(1):13-24. DOI:  https://doi.org/10.1007/s00127-020-01924-7.
  7. Talevi D., Socci V., Carai M, Carnaghi G, Faleri S, Trebbi E, et al. Mental health outcomes of the COVID-19 pandemic. Riv Psichiatr. 2020 May-Jun;55(3):137-144. DOI:  https://doi.org/10.1708/3382.33569.
  8. Mental health during the COVID-19 pandemic (features of psychological crisis, anxiety, fear and anxiety disorders) // NeuroNews. 2020. № 3 (114). Chaban O. S., Khaustova O. O. Mental health during the COVID-19 pandemic (features of psychological crisis, anxiety, fear and anxiety disorders). NeuroNews. 2020; 3(114):26-36.
  9. Mishchenko TS. Neurological complications in patients with COVID-19 / TS Mishchenko, VM Mishchenko // Psychiatry, Neurology and Medical Psychology, 2021. Issue 16. P. 23-33. M. Neurological complications in patients with COVID-19. Psychiatry, neurology and medical psychology. 2021;16:23-33. DOI:  https://doi.org/10.26565/2312-5675-2021-16-03. (In Ukrainian).
  10. Sher L. The impact of the COVID-19 pandemic on suicide rates. QJM: An International Journal of Medicine. 2020 Oct 1;113(10):707-712. DOI:  https://doi.org/10.1093/qjmed/hcaa202.
  11. Mental disorders in patients with coronavirus disease Covid-19, psychological aspect / Maruta N.O., Fedchenko V.Y., Panko T.V. [et al. 2023. Vol. 31, Issue 2 (115). P. 54-62. O., Fedchenko V. Yu., Panko T. V., Semikina O. Ye., Lapinska O. R. Mental disorders in patients who have recovered from the coronavirus disease Covid-19, psychological aspect. Ukrainian Bulletin of Psychoneurology. 2023; 31;2(115):54-62. DOI: https://doi.org/10.36927/2079-0325-V31-is2-2023-7. (In Ukrainian).
  12. McLaughlin KA, Rosen ML, Kasparek SW, Rodman AM. Stress-related psychopathology during the COVID-19 pandemic. Behav Res  Ther. 2022 Jul;154:104121. DOI:  https://doi.org/10.1016/j.brat.2022.104121.
  13. Meaklim H, Saunders WJ, Byrne ML, Junge MF, Varma P, Finck WA, Jackson ML. Insomnia is a key risk factor for persistent anxiety and depressive symptoms: A 12-month longitudinal cohort study during the COVID-19 pandemic. J Affect Disord. 2023 Feb 1;322:52-62. DOI: https://doi.org/10.1016/j.jad.2022.11.021.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»